What We Do
To advance global cancer research, build expertise, improve cancer prevention and cancer screening in low- and middle-income countries (LMICs), and reduce cancer deaths worldwide, the Center for Global Health facilitates research efforts through collaboration with U.S. government agencies, foreign governments, non-governmental organizations, and pharmaceutical and biotechnology companies. Some of what we do includes:
- Monitor NCI’s international collaborations and coordinate international activities across NCI
- Disseminate information and best practices that drive improvements in cancer research and cancer control
- Create and strengthen U.S. national, regional, multilateral, and bilateral collaboration and partnerships in health research, cancer research, and cancer control
- Develop and implement plans relevant to global health to inform cancer control and provide technical assistance as countries work to implement cancer control programs
- Train investigators and help develop research capacity in global health across the cancer continuum, both in the United States and in the developing world
- Develop and validate new agents and devices for cancer prevention, screening, diagnostics, treatment, and symptom management appropriate for use in the developing world
- Identify the research opportunities that are likely to have major effects on the burden of cancer throughout the world, and support programs that address global gaps in research and scientific training
CGH Priority Areas
To advance this vision, we have identified three priority areas in which we focus CGH programs and activities.
Strengthening Global Cancer Research and Resource-Appropriate Cancer Control Strategies
CGH's vision is to be a catalyst to reduce the global burden of cancer through coordination, collaboration, and communication among a diverse range of international stakeholders. We focus on supporting research and planning for cancer control, addressing all areas of the continuum from prevention—including risk factors common to other non-communicable diseases (NCDs)—and early detection, to treatment and palliative care. Cross cutting areas, which include cancer surveillance and epidemiology, implementation and dissemination of evidence-based interventions, and global health diplomacy through cancer research, among others, are also of key importance.
Building a Global Cancer Research Community
Sustainable partnerships in the landscape of global cancer control are an essential part of our work. CGH collaborates with national and international partners, both internal and external to the U.S. government, including foreign governments, academic institutions, and non-governmental organizations. Through these partnerships, we are building a global cancer research community to support activities that improve cancer research and cancer control in LMICs. This work is mutually defined by our priorities and the partner country’s own priorities and needs, in response to the growing burden of cancer and other NCDs. We aim to fund rigorous empirical research and guide evidence-based program implementation and translation into policies and programs, for long-term sustainability and to address various needs in global cancer control research and planning.
Translating Research Results Into Practice
To strengthen research and planning for cancer control and sustain partnerships globally, it is our responsibility to translate the results of the efforts we support, setting an example of accountability and generating evidence that can be used to prioritize next steps and improve decision making. Through the dissemination of the results and the impact of CGH activities, we contribute to best practices for cancer control and help improve the body of knowledge in the various fields along the cancer control continuum. It is also an important component for continued communication with our partners, and for establishing new partnerships. At CGH, our constant efforts to monitor and evaluate our activities ensure that the research and cancer control programs we support are having the intended impact in the field, and help us identify areas for improvement in future years.
The intersection of the three CGH priority areas ensures that the cancer research and control efforts we support are evidence-based and sustainable in LMICs.The areas complement one another to create an opportunity for empirical research, develop human resources and infrastructure, and sustain partnerships that will help carry the work forward in the years to come.